Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clebopride versus placebo for clinically suspected rumination syndrome
2024-516573-71-00Phase 4Authorised
- Sponsor
- UZ Leuven
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of clebopride and Placebo-COD Research Private Ltd in rumination disorder (2 arms), sponsored by UZ Leuven. Primary endpoint: Overall treatment evaluation. Planned start Oct 2019; status: authorised.
02
Drugs
clebopridePlacebo-COD Research Private Ltd
03
Conditions
rumination disorder
Beyond the preview
Go deeper on 2024-516573-71-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516573-71-00.